Software Optimized on Mira Advances Design of Mini-Proteins for Medicines, Materials
Friday, February 12, 2016 - 12:40
in Biology & Nature
Scientists at the University of Washington are using Mira to virtually design unique, artificial peptides, or short proteins. Peptides have the best properties of two different classes of medical drugs today and could enable future, peptide-based medicines with few side effects. As researchers begin to develop new peptides, they are optimizing their in-house software to test thousands of potential peptide structure designs in tandem, requiring a state-of-the-art supercomputer.